Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer

<p>PET and PET/CT using [<sup>11</sup>C]- and [<sup>18</sup>F]-labelled choline derivates is increasingly being used for imaging of primary and recurrent prostate cancer. While PET and PET/CT with [<sup>11</sup>C]- and [<sup>18</sup>F]-labelled c...

Full description

Bibliographic Details
Main Author: S. Schwarzenb&#246;ck, M. Souvatzoglou, B. J. Krause
Format: Article
Language:English
Published: Ivyspring International Publisher 2012-01-01
Series:Theranostics
Online Access:http://www.thno.org/v02p0318.htm
_version_ 1828870720738820096
author S. Schwarzenb&#246;ck, M. Souvatzoglou, B. J. Krause
author_facet S. Schwarzenb&#246;ck, M. Souvatzoglou, B. J. Krause
author_sort S. Schwarzenb&#246;ck, M. Souvatzoglou, B. J. Krause
collection DOAJ
description <p>PET and PET/CT using [<sup>11</sup>C]- and [<sup>18</sup>F]-labelled choline derivates is increasingly being used for imaging of primary and recurrent prostate cancer. While PET and PET/CT with [<sup>11</sup>C]- and [<sup>18</sup>F]-labelled choline derivates in patients suffering from biochemical recurrence of prostate cancer has been examined in many studies that demonstrate an increasing importance, its role in the primary staging of prostate cancer is still a matter of debate.</p><p>Morphological and functional imaging techniques such as CT, MRI and TRUS have demonstrated only limited accuracy for the diagnosis of primary prostate cancer. Molecular imaging with PET and PET/CT could potentially increase accuracy to localize primary prostate cancer. A considerable number of studies have examined the value of PET/CT with [<sup>11</sup>C]- and [<sup>18</sup>F]- labelled choline derivates for the diagnosis of primary prostate cancer with mixed results. Primary prostate cancer can only be detected with moderate sensitivity using [<sup>11</sup>C]- and [<sup>18</sup>F]choline PET and PET/CT. The detection rate depends on the tumour configuration. Detection is also limited by a considerable number of microcarcinomas that cannot be detected due to partial volume effects. Therefore small and in part rind-like tumours can often not be visualized. Furthermore, the differentiation between benign changes like prostatitis, high-grade intraepithelial neoplasia (HGPIN) or prostatic hyperplasia is not always possible. Therefore, at the present time, the routine use of PET/CT with [<sup>11</sup>C]- and [<sup>18</sup>F]-labelled choline derivates cannot be recommended as a first-line screening procedure for primary prostate cancer in men at risk. A potential application of choline PET and PET/CT may be to increase the detection rate of clinically suspected prostate cancer with multiple negative prostate biopsies, for example in preparation of a focused re-biopsy and may play a role in patient stratification with respect to primary surgery and radiation therapy in the future.</p>
first_indexed 2024-12-13T06:16:36Z
format Article
id doaj.art-0ecad4ca9c32448d8a98bf4f1e7aa49f
institution Directory Open Access Journal
issn 1838-7640
language English
last_indexed 2024-12-13T06:16:36Z
publishDate 2012-01-01
publisher Ivyspring International Publisher
record_format Article
series Theranostics
spelling doaj.art-0ecad4ca9c32448d8a98bf4f1e7aa49f2022-12-21T23:56:56ZengIvyspring International PublisherTheranostics1838-76402012-01-0121318330Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate CancerS. Schwarzenb&#246;ck, M. Souvatzoglou, B. J. Krause<p>PET and PET/CT using [<sup>11</sup>C]- and [<sup>18</sup>F]-labelled choline derivates is increasingly being used for imaging of primary and recurrent prostate cancer. While PET and PET/CT with [<sup>11</sup>C]- and [<sup>18</sup>F]-labelled choline derivates in patients suffering from biochemical recurrence of prostate cancer has been examined in many studies that demonstrate an increasing importance, its role in the primary staging of prostate cancer is still a matter of debate.</p><p>Morphological and functional imaging techniques such as CT, MRI and TRUS have demonstrated only limited accuracy for the diagnosis of primary prostate cancer. Molecular imaging with PET and PET/CT could potentially increase accuracy to localize primary prostate cancer. A considerable number of studies have examined the value of PET/CT with [<sup>11</sup>C]- and [<sup>18</sup>F]- labelled choline derivates for the diagnosis of primary prostate cancer with mixed results. Primary prostate cancer can only be detected with moderate sensitivity using [<sup>11</sup>C]- and [<sup>18</sup>F]choline PET and PET/CT. The detection rate depends on the tumour configuration. Detection is also limited by a considerable number of microcarcinomas that cannot be detected due to partial volume effects. Therefore small and in part rind-like tumours can often not be visualized. Furthermore, the differentiation between benign changes like prostatitis, high-grade intraepithelial neoplasia (HGPIN) or prostatic hyperplasia is not always possible. Therefore, at the present time, the routine use of PET/CT with [<sup>11</sup>C]- and [<sup>18</sup>F]-labelled choline derivates cannot be recommended as a first-line screening procedure for primary prostate cancer in men at risk. A potential application of choline PET and PET/CT may be to increase the detection rate of clinically suspected prostate cancer with multiple negative prostate biopsies, for example in preparation of a focused re-biopsy and may play a role in patient stratification with respect to primary surgery and radiation therapy in the future.</p>http://www.thno.org/v02p0318.htm
spellingShingle S. Schwarzenb&#246;ck, M. Souvatzoglou, B. J. Krause
Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
Theranostics
title Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
title_full Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
title_fullStr Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
title_full_unstemmed Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
title_short Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
title_sort choline pet and pet ct in primary diagnosis and staging of prostate cancer
url http://www.thno.org/v02p0318.htm
work_keys_str_mv AT sschwarzenb246ckmsouvatzogloubjkrause cholinepetandpetctinprimarydiagnosisandstagingofprostatecancer